Dendrite Licenses Verispan Patient Data

Share this article:
Dendrite International will license anonymous patient-level data from healthcare information company Verispan, the provider of pharmaceutical industry solutions said yesterday.


The data, coupled with proprietary analytics from Dendrite, Bedminster, NJ, will let Dendrite customers more precisely identify prescribers at specific points in their individual product adoption curve and develop direct, prescriber-specific messaging or activities.


Collection of anonymous patient-level data through a network of pharmacies originally was conducted by Dendrite when no other suitable data sources were available. In the past five years, Verispan, Yardley, PA, has expanded the quality and depth of its data. As a result, Dendrite no longer needs to collect its own data.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in News

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in News

De Quinto Tapped as Coke's Next CMO

De Quinto Tapped as Coke's Next CMO

The president of the company's Iberia Business Unit will take over from Joe Tripodi upon his retirement in February.

Customer Centricity Is Spurring Marketing-Tech Investments

Customer Centricity Is Spurring Marketing-Tech Investments

A majority of marketers rank customer satisfaction improvements as paramount in the technology investment decisions.

Big, Bold Moves in the C-Suite

Big, Bold Moves in the C-Suite ...

JCPenney appoints Home Depot's Marvin Ellison as CEO; Harte Hanks and JWT add hitting power to their C-level benches